Attachment of Idarubicin to Glutaraldehyde-coated Magnetic Nanoparticle and Investigation of its Effect in HL-60 Cell Line

Basit Öğe Kaydı
dc.contributor.authorUlusal, Hasan
dc.contributor.authorUlusal, Fatma
dc.contributor.authorBozdayi, Mehmet Akif
dc.contributor.authorGüzel, Bilgehan
dc.contributor.authorTaysı, Seyithan
dc.contributor.authorTarakçıoğlu, Mehmet
dc.date.accessioned2025-03-17T12:18:42Z
dc.date.available2025-03-17T12:18:42Z
dc.date.issued2022
dc.departmentTarsus Üniversitesi
dc.description.abstractIdarubicin is a chemotherapeutic drug frequently used to treat breast cancer and acute leukemia. This study aimed to immobilize idarubicin on glutaraldehyde (GA)-coated magnetic nanoparticles (MNP-GA) to prepare a drug with high stability and low toxicity. We prefreed MNPS because of their easy synthesis, low cost, and non-toxicity. In the study, magnetite (Fe3O4) nanoparticles were prepared, coated with glutaraldehyde, characterization processes were performed with Fourier transform infrared spectroscopy (FT-IR), X-ray diffraction pattern (XRD), and Conventional transmission electron microscopy (C-TEM) methods, and idarubicin (IDA) was bound. The cytotoxic effects of idarubicin-bound MNP-GA and free idarubicin on HL-60 cell lines were determined by MTT and ATP tests, and IC50 values were calculated. Flow cytometry was used to evaluate apoptosis status, and the expression of MDR1, Puma, NOXA, BAX, Survivin, and BCL-2 genes were measured by the polymerase chain reaction (PCR). It was found that the IC50 decreased between 5 and 7 times with the use of MNP. In PCR tests, the expressions of apoptotic genes increased, while the expressions of MDR1 and anti-apoptotic genes were decreased in the use of MNP. Apoptosis was found to be increased in flow cytometry measurements. The use of MNP systems has reduced drug resistance since it provides controlled release of the drug and prevents its exit from the cell due to its structure.
dc.identifier.doi10.32571/ijct.1194667
dc.identifier.endpage163
dc.identifier.issn2602-277X
dc.identifier.issue2
dc.identifier.startpage154
dc.identifier.trdizinid1159212
dc.identifier.urihttps://doi.org/10.32571/ijct.1194667
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/1159212
dc.identifier.urihttps://hdl.handle.net/20.500.13099/946
dc.identifier.volume6
dc.indekslendigikaynakTR-Dizin
dc.language.isoen
dc.relation.ispartofInternational Journal of Chemistry and Technology (IJCT)
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_TR_20250316
dc.subjectIdarubicin
dc.subjectAcute Promyelocytic Leukemia
dc.subjectGlutaraldehyde
dc.subjectHL-60 Cell Line
dc.subjectMagnetic Nanoparticles
dc.titleAttachment of Idarubicin to Glutaraldehyde-coated Magnetic Nanoparticle and Investigation of its Effect in HL-60 Cell Line
dc.typeArticle

Dosyalar

Koleksiyon

TR-Dizin İndeksli Yayınlar Koleksiyonu